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Abstract
An attempt was made to establish the method for the estimation of glucuronide formation in
vivo using salicylamide and further to study the alteration in the glucuronide formation in liver
disease. The results were as follows: 1. The method for the determination of free salicylamide
separately from other conjugates of salicylamide in urine, without involving any hydrolysis of the
other conjugates, was presented. When 1 g. of salicylamide was administered to the subjects
with or without liver injuries, no free salicylamide was detected by the present method in the
urine following the salicylamide administration. 2. The analytical method for the determination
of salicylamide glucuronide was also devised by employing a hydrolysis with β-glucuronidase.
The ratio of the salicylamide liberated by the enzymatic hydrolysis of the 10-hour urine following
the administration of 1 g. of salicylamide to the total salicylamide excreted in the same urine was
neither affected by the total recovery of the salicylamide nor by the urine volume. This ratio was
thus used as a means of estimating the capacity of the glucuronide formation in vivo, although
it was considered that the ratio might be affected to some extent by the competition between the
glucuronide and other conjugate formations in vivo. 3. As a result of this salicylamide glucuronide
excretion test, it was indicated that the in vivo formation of salicylamide glucuronide in the patients
with postnecrotic cirrhosis was slightly decreased compared with that in normal controls.
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The determination of the glucuronide formation in vivo has been based on
the estimation of the urinary excreted glucuronic acid after administration of
the substance to be conjugated with glucuronic acid, such as camphor, borneol,
and menthoP. The method of SANPPER and SALTZMAN2•3 using benzoic acid as a
test substance for this purpose was not a suitable means of estimating mainly the
glucuronide formation in vivo without reference to other conjugate formations,
because the principle of their method was based on the competition between
glycine and glucuronic acid conjugations for benzoic acid. BARNIVILLE and MISK4,
for the same purpose, used salicylamide which was known to be conjugated in
vivo primarily with glucuronic acid. However, their means also depended on
the determination of the glucuronic acid increased in the urine following salicyl-
amide load. SCHMID and HAMMAKER6, also for this purpose, administered N-
acetyl-p-aminophenol and determined the corresponding glucuronide in the blood
and urine specifically by employing a hydrolysis with p-glucuronidase. This
method was considered, however, to be still imperfect in that N-acetyl-p-amino-
phenol appeared to be conjugated in vivo less favorably with glucuronic acid
than with other substances, such as sulfuric acid.
In view of these unsatisfactory methods and the results obtained therefrom,
present study was made attempting to establish a specific method of estimating
the in vivo formation of glucuronide in human subject and to apply it to the
patients with liver disease. For this purpose salicylamide was selected as a test
substance, because it was known to be rapidly absorbed, excreted in urine
mainly as its etherial glucuronide6, and also non-toxic.
MATERIALS AND METHODS
Five normal subjects, 19 patients with viral hepatitis including 4 with
acute hepatitis, 2 with acute exacerbation of chronic hepatitis, 7 with chronic
hepatitis, and 6 with postnecrotic cirrhosis, and 2 patients with Dubin-Johnson
syndrome, all hospitalized to Okayama University Hospital were subjected to a
salicylamide glucuronide excretion test. All these clinical diagnoses were con-
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firmed by peritoneoscopy, histological examination of the liver, and chemical
tests for liver function. The procedures of the salicylamide glucuronide excretion
test were as follows.
The subject was allowed to take dinner at 5: 00 p. m. and fasted thereafter.
The administrations of the drugs capable of being conjugated with glucuronic
acid or of the drugs containing phenolic compounds were also withheld during
the period of this test. A dose of 1 g. salicylamide was administered orally with
approximately two hundred ml. of water at 10: 00 p. m., and the following 10-
hour urine was collected. This urine sample was immediately subjected to the
following analyses after measurement of the urine volume. Total and free salicyl-
amide and salicylamide glucuronide were analyzed according to the following
modifications of the method described by BRODIE and others7 for the determina-
tion of salicylic acid and of the method described by CRAMPTON and Voss8 for
the determination of salicylamide.
Analysis of Total Salicylamide in Urine: A one-thousandth part of the
volume of the 10-hour urine sample was placed in a 50 ml. centrifuge tube with
a well-fitting glass stopper and diluted to 1 ml. with distilled water. One ml. of
concentrated hydrochloric acid was added to the diluted urine sample. The tube
was closed with the glass stopper and placed in a boiling water bath for 15 mi-
nutes!), and then cooled in running tap water. To the hydrolyzed urine, 2 ml.
of distilled water followed by 25 ml. of benzene2) was added and the tube was
shaken vigorously for one minute. After centrifugation of the tube, 15 ml. of
the organic phase was transferred to another similar centifuge tube receiving
2 ml. of 0.05 N sodium hydroxide and the tube was again shaken vigorously
for one minute followed by centrifugation. One ml. of the aqueous phase was
transferred to a test tube. To the tube, 1.5 ml. of 0.1 M glycine buffer, pH 2.6,
1.5 ml. of ferric nitrate solution one per cent in 0.07 N nitric acid, and 2 ml. of
distilled water were added in this order. The optical density of this solution was
read at a wave length of 535 mll. against the control solution which was similarly
prepared from 1 ml. of 0.05 N sodium hydroxide by adding the buffer, the
reagent, and waterS). Concentration of the salicylamide was determined by a
1) CRAMPTON and VOSS8 hydrolyzed conjugated salicylamide in 1 N hydrochloric acid for six
hours in a boiling water bath. In the present method, however, the time required for the
hydrolysis was reduced to fifteen minutes by employing the hydrolysis in 6 N hydrochloric acid
in a boiling water bath. Under this condition, the hydrolysis was complete and did not involve
any degradation of salicylamide.
2) Benzene was substituted for ethylene dichloride which was generally used for the extrac-
tion of salicylic acid7 and salicylamide8, because benzene facilitated the extraction of salicylamide
from a weak acid medium to a satisfactory degree.
3) Various substances contained in urine did not interfere with salicylamide in the processes
of the extractions, the color developement, and the colorimetry.
2
Acta Medica Okayama, Vol. 16 [1962], Iss. 3, Art. 2
http://escholarship.lib.okayama-u.ac.jp/amo/vol16/iss3/2
Formation of Salicylamide Glucuronide 131
comparison with the standard curve prepared from aqueous salicyamide solutions
with varied concentrations. The amount of the salicylamide liberated by the acid
hydrolysis was calculated and expressed in terms of total salicylamide.
Analysis of Salicylamide Glucuronide in Urine: A one-thousandth part of
the volume of the 10-hour urine sample was placed in a similar centrifuge tube
and diluted to I m!. with distilled water. Two ml. of 0.2 M acetate buffer, pH
6.0, containing 80 units of bacterial fi-glucuronidase was added to the diluted
urine sample, which was then incubated for 5 hours') at 37°C and then cooled
in running tap water. To the enzymatically hydrolyzed urine, I m!. of I N
hydrochloric acid was added, and the salicylamide being present in the hydroly-
zed urine was extracted with 25 m!. of benzene. The amount of the extracted
salicylamide was determined thereafter by the same procedure as described for
the measurement of total salicylamide. From this amount of salicylamide, the
amount of the free salicylamide existed in the original urine before the hydrolysis
was subtracted in order to obtain a net amount of the salicylamide derived from
salicylamide glucuronide following the hydrolysis. This amount of the salicyl-
amide liberated by the enzymatic hydrolysis was expressed in terms of salicyl-
amide glucuronide.
Analysis of Free Salicylamide in Urine: A one-two hundred and fiftieth
part of the volume of the 10-hour urine sample was placed in a similar centrifuge
tube and diluted to 3 ml. with distilled water. One m!. of I N hydrochloric
acid~) was added to the diluted urine sample, and free salicylamide was extracted
with 25 m!. of benzene. The amount of the free salicylamide was determined
thereafter by the same procedure as described for the measurement of total
salicylamide.
RESULTS
Urinary excretion of salicy.amide glucuronide in case of the administration
of varied amounts of salicylamide to a normal subject was estimated and indica-
ted in Table 1. With the increase in the amount of salicylamide administered,
not only the amount of salicylamide glucuronide excreted in urine but also the
4) The liberation of salicylamide from the salicylamide glucuronide contained in the urine
sample, following the hydrolysis with ft·glucuronidase, was almost complete even in 2 hours of
incubation under the present conditions. On the other hand, in the case of the incubation of a
similar sample without the addition of ft-glucuronidase, the liberation of salicylamide was not
observed even in 5 hours of incubation. No sulfatase activity was demonstrated in the P-glu-
curonidase used in the present assay.
5) The amount of salicylamide extracted with benzene from the urine sample with the addi·
tion of 1 N hydrochloric acid was equal to that extracted from the urine sample in 3 N hydro.
chloric acid, while the hydrolysis of conjugated salicylamide was not involved at all in the pro-
cess of extraction from the urine with the addition of 1 N hydrochloric acid.
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Table 1. Total salicylamide, free salicylamide, and salicylamide glucuronide
excreted in urine following each administration of varied
amounts of salicylamide to a normanl subject
Salicylamide Administered (mg.) I 100 I 300 I 1000 I 2000
Total salicylamide excreted (mg. ) 85 259 831 1724
Free salicylamide excreted (mg.) 0 0 0 0
Salicylamide glucuronide excreted (mg. ) 22 98 527 1202
G/T* (%) 25.9 37.9 63.4 69.7
* G/T Salicylamide glucuronide excreted X 100
Total salicylamide excreted
The amounts of total salicylamide and salicylamide glucuronide are each expressed as mg.
of the salicylamide liberated by each hydrolysis.
ratio of the salicylamide glucuronide to the total salicylamide was increased.
The results of a preliminary experiment indicated that following the administra-
tion of 1 g. of salicylamide a normal subject excreted urinary salicylamide more
than sixty per cent of the administered salicylamide in 5 hours, more than eighty
per cent in 10 hours, and a far less amount thereafter. As shown in Table 2,
the patients with liver disease also excreted more than eighty per cent of the
administered salicylamide into the following la-hour urine. No free salicylamide
was detected in the urine in all of these cases.
The amount of the salicylamide liberated following the hydrolysis of the
conjugated salicylamide in the urine sample with ,a·glucuronidase was almost
constant even when ·more than 80 units of ,a-glucuronidase were added to the
sample and the mixture was incubated more than 5 hours at 37 QC. The total
recovery of the administered salicylamide from the 10-hour urine was not affec-
ted by the volume of the urine. The ratio of the salicylamide glucuronide in the
la-hour urine to the total salicylamide in the same urine, (G/T), was not also
affected by the total recovery and the urine volume.
The GIT ratios in 5 normal controls were 54 to 64 per cent. Those in
postnecrotic cirrhosis were slightly lower, while those in Dubin-Johnson syn-
drome were slightly higher. To some of these patients, 5 per cent glucose solu-
tion was intravenoulsy administered as a curative drug immediately before the
salicyamide glucuronide cxcretion test. The GIT ratios in the patients treated
with the glucose all remained above the lower range of the normal and appeared
to be slightly higher than those in the patients who were not treated with the
glucose. On the other hand, the administration of glucuronic acid preparations
failed to cause such an increased excretion of the glucuronide. There was not an
apparent relationship between the GIT ratio and the result of routine tests for
liver function.
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Table 2. Urine volume, total salicylamide, free salicylamide, and salicylamide glucuro-
nide of 10-hour urine following the administration of 1 g. of salicylamide
in normal subjects and the patients with liver disease
133
I Urine Salicylamide ExcretedClinical Diagnosis Patient Volume
I
I glucuronide Itotal free G/T*
m!. mg. mg. mg. 96
Normal control KT. 380 831 0 527 63.4
S.H. 360 862 0 541 62.8
Y.N. 156 840 0 527 62.7
KK 126 860 0 461 53.6
T.H.t 390 873 0 491 56.2
Acute viral hepatitis · H.T.§ 255 886 0 479 54.1
• H.N.t 226 887 0 521 58.7
S.N.§ 395 911 0 582 63.9
• S.N. t 220 888 0 591 66.6
ACl,1te exacerbation of chronic • A.I. 430 814 0 495 60.8
viral hepatitis S. Y. t 240 862 0 352 40.8
Chronic viral hepatitis KI. 490 836 0 511 61.1
S.H. 250 897 0 512 57.1
M.T. 210 862 0 515 59.7
D.S.§ 490 928 0 549 59.2
T.H.t 270 851 0 542 63.7
Y.S. 290 889 0 478 53.8
· K.Y. 240 888 0 540 60.8
Postnecrotic cirrhosis Y. I. 360 912 0 463 50.8
KT. 430 851 0 358 42.1
T. K 650 850 0 358 42.1
• G.T. 490 907 0 531 58.5
• U.K. t 740 888 0 511 57.5
T.Y. 218 937 0 571 60.9
Dubin-Jonson syndrome • S.M. 223 888 0 622 70.0
H.M. 345 899 0 647 72.0I
* G/T Salicylamide glucuronide excreted X 100
Total salicylamide excreted
The amounts of total salicylamide and salicylamide glucuronide are each expressed as mg.
of the salicylamide liberated by each hydrolysis. " case with an intravenous infusion of 500 to
1000 m!. of 5 per cent glucose solution immediately before this test; §, case with daily oral
administration of 2 g. of sodium glucuronate as a curative drug; t. case with daily oral admi-
nistration of 2 g. of glucuronamide as a curative drug.
DISCUSSION
In the analysis of salicylamide glucuronide, the degree of the enzymatic
hydrolysis was a problem. Since in the present study the hydrolysis 'of salicyl-
amide glucuronide with ;9-glucuronidase was constant and reproducible, the
amount of salicylamide glucuronide measured by the enzymatic hydrolysis was
considered as equal to the amount of the whole salicylamide glucuronide actually
contained in the urine sample, or even if not, as proportional to the whole
salicylamde glucuronide. Hence, at any rate, the amount of salicylamide glu-
curonide determined by the enzymatic hydrolysis could be used as a measure of
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glucuronide formation in vivo.
The amount of total salicylamide excreted in the 10-hour urine sample was
almost constant, ranging from 800 to 950 mg., without reference to the volume
of the urine sample. The G/T ratio was also neither affected by the urine volume
nor by the amount of the total salicylamide excreted. Accordingly, the possible
effect ~f renal funtion on the G/T ratio was considered not to be involved to
an appreciable extent. In this connection, the G/T ratio was considered to serve
as representing the capacity of glucuronide formation in vivo without reference
to renal function.
The evidence in the present experiment that no free salicylamide was
detected in the urine following the administration of salicylamide disagreed with
the results obtained by other workers6•9• Since, however, free salicylamide was
extracted with benzene from a weak acid medium to the same degree as. from
the strong acid medium, it was rather convincing that in the human subjects
tested no free salicylamide was excreted in the urine following the administra-
tion of 1 g. of salicylamide.
MANDEL and others6 reported that when 300 mg. of C14 salicylamide was
administered to the patient with advanced carcinoma of the cervix and with
normal liver function, most of the urinary metabolites was accounted for as the
etherial glucuronide and no other metabolites, except the etherial sulfate in a
negligible amount, were excreted. In the present study, however, the glucuro-
nide portion of the total salicylamide excreted in the urine was only 25.9 per
cent when 300 mg. of salicylamide was administered to a normal subject, and
it rather increased in accordance with the increase in the amount of salicylamide
administered. This result indicated that when a smaller amount of salicylamide
was administered, the salicylamide preferred to form the other conjugate than
the glucuronide, possibly the sulfate, rather than to form the glucuronide, and
when a larger amount of salicylamide was administered, the glucuronide con-
jugation was increased compensatory. Accordingly, it was considered that it
was necessary to administer more than 1 g. of salicylamide in order to estimate
the capacity of glucuronide formation. This was further supported by the result
in a previous reporeo that the glucuronyl transferase activity of liver tissue cor-
related significantly with the G/T ratio obtained following the administration
of 1 g. of salicylamide.
The result that the patients with postnecrotic cirrhosis indicated lower G/T
ratio than that in normal subjects was pertinent with the result of BARNIVILLE and
MISK4• The other patients with viral hepatitis indicated the G/T ratio within
the normal range, and thus this salicylamide glucuronide excretion test was not
so sensitive as to be utilized as a liver function test.
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SUMMARY
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An attempt was made to establish the method for the estimation of glucuro-
nide formation in vivo using salicylamide and further to study the alteration in
the glucuronide formation in liver disease. The results were as follows:
1. The method for the determination of free salicylamide separately from
other conjugates of salicylamide in urine, without involving any hydrolysis of the
other conjugates, was presented. When 1 g. of salicylamide was administered
to the subjects with or without liver injuries, no free salicylamide was detected
by the present method in the urine following the salicylamide administration.
2. The analytical method for the determination of salicylamide glucuronide
was also devised by employing a hydrolysis with p-glucuronidase. The ratio
of the salicylamide liberated by the enzymatic hydrolysis of the IQ-hour urine
following the administration of 1 g. of salicylamide to the total salicylamide
excreted in the same urine was neither affected by the total recovery of the
salicylamide nor by the urine volume. This ratio was thus used as a means of
estimating the capacity of the glucuronide formation in vivo, although it was
considered that the ratio might be affected to some extent by the competition
between the glucuronide and other conjugate formations in vivo.
3. As a result of this salicylamide glucuronide excretion test, it was indi-
cated that the in vivo formation of salicylamide glucuronide in the patients with
postnecrotic cirrhosis was slightly decreased compared with that in normal cont-
rols.
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